X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
female (8) 8
index medicus (8) 8
male (8) 8
hematology (7) 7
middle aged (7) 7
adult (6) 6
aged (6) 6
aged, 80 and over (6) 6
oncology (6) 6
imatinib (5) 5
therapy (4) 4
further section (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3) 3
medicine (3) 3
treatment outcome (3) 3
allogeneic stem cell transplantation (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
chromosomes, human, pair 5 (2) 2
chronic myeloid leukemia (2) 2
chronic myelomonocytic leukemia (2) 2
cml (2) 2
genes (2) 2
hematology, oncology and palliative medicine (2) 2
hypomethylating agents (2) 2
imatinib mesylate - therapeutic use (2) 2
iron (2) 2
leukemia (2) 2
myelodysplastic syndromes (2) 2
myelodysplastic syndromes - complications (2) 2
myelodysplastic syndromes - genetics (2) 2
platelet count (2) 2
resistance (2) 2
treatment (2) 2
young adult (2) 2
5-aminolevulinate synthase (1) 1
5-aminolevulinate synthetase - genetics (1) 1
5-aminolevulinate synthetase - metabolism (1) 1
abcb1 (1) 1
abcg2 (1) 1
age (1) 1
age factors (1) 1
aged patients (1) 1
alas2 (1) 1
allogeneic haematopoietic stem cell transplantation (1) 1
analysis (1) 1
anemia, aplastic - blood (1) 1
anemia, aplastic - drug therapy (1) 1
anemia, sideroblastic - drug therapy (1) 1
anemia, sideroblastic - enzymology (1) 1
anemia, sideroblastic - genetics (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - blood (1) 1
antineoplastic agents - pharmacokinetics (1) 1
association (1) 1
base sequence (1) 1
benzamides - blood (1) 1
benzamides - pharmacokinetics (1) 1
benzamides - therapeutic use (1) 1
benzoates - therapeutic use (1) 1
bioinformatics (1) 1
biomarkers - analysis (1) 1
blast crisis (1) 1
blood platelets - pathology (1) 1
blood transfusion (1) 1
care and treatment (1) 1
cell line, tumor (1) 1
cell-associated concentration (1) 1
cell‐associated concentration (1) 1
chelation therapy - adverse effects (1) 1
chelation therapy - statistics & numerical data (1) 1
chelation-therapy (1) 1
chromosome aberrations (1) 1
chromosome deletion (1) 1
chronic myelogenous leukemia (1) 1
chronic myeloid leukaemia (1) 1
chronic myeloid-leukemia (1) 1
chronic-phase (1) 1
clinical medicine (1) 1
clinical research (1) 1
clinical response (1) 1
clinical-response (1) 1
comorbidities (1) 1
comparative analysis (1) 1
cytogenetic responses (1) 1
deferasirox, chelation (1) 1
deferasirox,chelation (1) 1
deferiprone (1) 1
design (1) 1
dextrose (1) 1
diabetes therapy (1) 1
dosage (1) 1
dose-response relationship, drug (1) 1
drug dosages (1) 1
drug therapy, combination (1) 1
enzyme (1) 1
epstein-barr virus (1) 1
epstein-barr virus infections - etiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5905 - 5905
Patients with newly diagnosed chronic myeloid leukemia (CML) frequently receive imatinib. Although initial response rates are high, imatinib fails in up to 40%... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1647 - 1647
Introduction: The single nucleotide polymorphism (SNP) rs460089 (G/C) located in the promotor of SLC22A4 (transporter hOCTN1) was identified as a prognostic... 
Journal Article
Archives of Medical Science, ISSN 1734-1922, 2018, Volume 14, Issue 6, pp. 1416 - 1423
Introduction: Imatinib mesylate is the drug of choice for patients with chronic myeloid leukemia (CML). Imatinib pharmacokinetics is affected by a number of... 
Imatinib | Chronic myeloid leukemia | Clinical response | Genetic polymorphisms | MANAGEMENT | ABCB1 | imatinib | genetic polymorphisms | clinical response | MEDICINE, GENERAL & INTERNAL | THERAPY | RELEVANCE | GENES | RESISTANCE | chronic myeloid leukemia | CLINICAL-RESPONSE | ASSOCIATION | ABCG2 | Leukemia | Clinical Research
Journal Article
Vnitrni lekarstvi, ISSN 0042-773X, 09/2015, Volume 61, Issue 9, p. 785
Journal Article
Journal Article
Leukemia Research, ISSN 0145-2126, 06/2019, Volume 81, pp. 67 - 74
•Tyrosine kinase inhibitors have changed the natural course of CML.•In the era of TKI age is losing its negative prognostic importance.•The responses of the... 
Chronic myeloid leukaemia | Imatinib | Treatment | Dosage | Age | CHRONIC MYELOGENOUS LEUKEMIA | CYTOGENETIC RESPONSES | YOUNG-ADULTS | SURVIVAL | TYROSINE KINASE | BLAST CRISIS | PREVALENCE | RANDOMIZED CML | ONCOLOGY | COMORBIDITIES | INHIBITOR | HEMATOLOGY | Antimitotic agents | Tyrosine | Aged patients | Antineoplastic agents | Analysis
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1813 - 1813
Abstract Background: Recently we have published results of pilot study on CML patients demonstrating fast development of hyperinsulinaemia, peripheral insulin... 
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 4051 - 4051
Abstract Abstract 4051 Poster Board III-986 Congenital sideroblastic anemias (SA) are hypochromic microcytic anemias with secondary iron overload. Local iron... 
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2014, Volume 32, Issue 2, pp. 87 - 93
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.